Last reviewed · How we verify

NCT07016425

Temporal Interference for Essential Tremor

Recruiting now NA Last updated 16 July 2025
What this trial tests

NA trial testing Temporal Interference in Essential Tremor in 10 participants. Currently enrolling.

Timeline
9 June 2025
Primary endpoint
30 May 2026
30 September 2026

Quick facts

Lead sponsorLiankun_Ren
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment10
Start date9 June 2025
Primary completion30 May 2026
Estimated completion30 September 2026
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Liankun_Ren

Who can join

Adults 30 to 70, any sex, with Essential Tremor. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This single-center prospective study aims to investigate the treatment efficacy of temporal interference (TI) in essential tremor patients aged 30-70.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Temporal Interference

Trials testing the same drug.

Other recruiting trials for Essential Tremor

Currently open trials in the same condition.

Other Liankun_Ren trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07016425.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing